FOS and hepatocellular carcinoma: A recent study has shown that aldo–keto reductase 1B10, which plays a critical role in tumor development and progression through promoting lipogenesis and eliminating cytotoxic carbonyls, is induced by insulin through the activator protein-1 (AP-1) signaling pathway in human hepatocellular carcinoma cells (277).